Emergency Neonatal Pulmonary & Metabolic Dysfunctions

Neonatal Respiratory Distress Syndrome (RDS)

Neonatal Surfactant Deficiency Pulmonary Disease

Primary risk age: Premature Neonates (Incidence increases with decreasing gestational age; rare in term infants)

Urgency: Emergency
Typical age: Premature Neonates (Incidence increases with decreasing gestational age; rare in term infants)
Body system: Neonatal (Newborns)

Typical course: RDS typically peaks at 48 to 72 hours of life; gradual recovery occurs over 4 to 7 days as the infant's lungs begin producing native surfactant.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Neonatal Surfactant Deficiency Pulmonary Disease

Pathophysiology (Development Path)

Surfactant reduces surface tension within the alveoli, keeping them open during expiration. Surfactant deficiency leads to widespread alveolar collapse (atelectasis) at the end of expiration. This results in poor lung compliance, intrapulmonary shunting, hypoxia, and the formation of hyaline membranes in the alveoli.

Primary Causes & Etiology

Developmental insufficiency of surfactant production by type II alveolar cells in the lungs of premature infants.

2. Symptom Continuum

Early Onset Signs
Tachypnea (rapid breathing $>60 ext{ breaths/minute}$), nasal flaring, and expiratory grunting presenting immediately at birth or within minutes of delivery.
Progressive Phase
Intercostal and subcostal retractions, paradoxical chest-abdominal motion ("seesaw breathing"), and audible grunting on every expiration.
Severe Indicators
Cyanosis (bluish tint) on room air, severe retractions, periods of apnea, hypotonia, and progressive respiratory failure.

3. Clinical Verification

Chest X-ray showing a characteristic diffuse "ground-glass" appearance and air bronchograms due to micro-atelectasis. Arterial blood gas demonstrating hypoxemia and respiratory acidosis.

4. Care & Elements Plan

Primary Care Treatment Plan

Administer exogenous surfactant directly into the trachea immediately after birth or when distress develops. Provide respiratory support using Continuous Positive Airway Pressure (CPAP) or mechanical ventilation. Maintain temperature and hydration.

Home Support Elements

Home care is strictly not applicable. This is a critical neonatal ICU emergency.

Generic Active Ingredients (No Brands)

Poractant alfa or Calfactant (generic active exogenous surfactant ingredients derived from animal lungs)
Caffeine citrate (active stimulant used to prevent apnea of prematurity).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Any newborn showing rapid breathing, grunting, or chest pulling in the delivery room or nursery requires immediate neonatal resuscitation and transfer to a NICU.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Administer prenatal corticosteroids (Betamethasone) to mothers in preterm labor (between 24-34 weeks gestation) to accelerate fetal lung maturation and surfactant production.

Immunization Context

No specific immunizations are associated with this developmental neonatal disease.

7. Timelines & Outlook

Active Timeline

RDS typically peaks at 48 to 72 hours of life; gradual recovery occurs over 4 to 7 days as the infant's lungs begin producing native surfactant.

Expected Prognosis

Excellent with modern surfactant therapy and CPAP; mortality is low in babies born $>28$ weeks. Extremely premature infants remain at risk for chronic lung disease.

Potential Untreated Complications

Bronchopulmonary dysplasia (chronic lung disease), air leaks (pneumothorax, pulmonary interstitial emphysema), intraventricular hemorrhage, and patent ductus arteriosus.

Moderate

Neonatal Jaundice (Hyperbilirubinemia)

Neonatal Bilirubin Metabolic Clearance Dysfunction

Neonates (Common in the first week of life; affects up to 60% of term and 80% of preterm infants)

Emergency

Persistent Pulmonary Hypertension of the Newborn (PPHN)

Neonatal Severe Right-to-Left Shunt Hypoxemia

Term or near-term neonates (onset within hours of birth)